Infectious Disease/Vaccine

PBMC Processing for Human Challenge Studies

Infectious Disease/Vaccine, Influenza, Videos

PBMC Processing for Human Challenge Studies

PBMC Processing for Human Challenge Studies When conducting Human Challenge Studies, WCCT processes peripheral mononuclear blood cells (PBMCs) for future testing. PBMC processing is a unique capability and one of WCCT’s core competencies. Through effective harvesting, processing, and analysis of PBMCs, researchers are able to evaluate immune responses to therapeutic...read more

4 years ago.

WCCT Global Presents on the Influenza Challenge Model at ISIRV 2016

Infectious Disease/Vaccine, Influenza, News, Press Release

WCCT Global Presents on the Influenza Challenge Model at ISIRV 2016

COSTA MESA, Calif./IReach–PRNewswire/–WCCT Global, a full-service CRO headquartered in Orange County, CA, presented the results of a recent clinical study which will make use of the influenza challenge model, a unique proof of concept study design for evaluating potential new vaccines or therapeutics which is dependent upon identifying individuals...read more

4 years ago.

WCCT Global Presents Results of Influenza Clinical Study at Annual ICAAC Meeting

CRO, Infectious Disease/Vaccine, News, Press Release

WCCT Global Presents Results of Influenza Clinical Study at Annual ICAAC Meeting

COSTA MESA, Calif.,/IReach-PRNewswire/–Orange County-based contract research organization WCCT Global presented the results of a recently-conducted influenza clinical study at the 2015 Annual ICAAC meeting hosted in San Diego, CA. The study was conducted at the CRO’s dedicated Influenza Challenge Research facility in Costa Mesa, CA. Between January and March...read more

5 years ago.

WCCT Global Collaborates with Dr. Gary Nolan’s Laboratory at Stanford for Influenza Clinical Research

Infectious Disease/Vaccine, News, Press Release

WCCT Global Collaborates with Dr. Gary Nolan’s Laboratory at Stanford for Influenza Clinical Research

  COSTA MESA, Calif., January 27, 2015/PRNewswire-iReach/—WCCT Global, a full service contract research organization (CRO) headquartered in Southern California, announced the establishment of a collaboration agreement with researchers in Dr. Garry P. Nolan’slaboratory from the Department of Microbiology and Immunology at Stanford University. Together with the National Institute of...read more

6 years ago.

Contract Research Organization WCCT Global Announced as One of Three Supporting Clinical Research Partners for DynPort Vaccine Development

Infectious Disease/Vaccine, News, Press Release

Contract Research Organization WCCT Global Announced as One of Three Supporting Clinical Research Partners for DynPort Vaccine Development

WCCT Global Chosen as Strategic Partner for Vaccine Development COSTA MESA, Calif., January 22, 2015/PRNewswire-iReach/—WCCT Global, a full service contract research organization was announced today to be a strategic partner with Dynport Vaccine Company along with two other CROs for supporting clinical trials to evaluate Anti-Infective Drugs with the...read more

6 years ago.

Contract Research Organization WCCT Global Announced Collaboration Agreement with the NIAID for Influenza Challenge Research

Infectious Disease/Vaccine, News, Press Release

Contract Research Organization WCCT Global Announced Collaboration Agreement with the NIAID for Influenza Challenge Research

  WCCT Global can Conduct Influenza Challenge Research in the United States COSTA MESA, Calif., January 15, 2015/PRNewswire-iReach/—WCCT Global a full service contract research organization headquartered in Southern California announced today the beginning of a collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) for influenza challenge...read more

6 years ago.

Contract Research Organization WCCT Global Announces Involvement in H1N1 Oral Vaccine Development

Infectious Disease/Vaccine, News, Press Release

Contract Research Organization WCCT Global Announces Involvement in H1N1 Oral Vaccine Development

  Successful Clinical Trial with WCCT Global’s H1N1 Oral Vaccine COSTA MESA, Calif., October 29, 2014/PRNewswire-iReach/—WCCT Global, a full Service Contract Research Organization headquartered in Southern California announced their involvement in a sentinel clinical trial designed to evaluate safety and immunogenicity signals from a novel h1n1 oral vaccine for...read more

6 years ago.

Influenza Challenge Research – WCCT Global Announces  Ownership of Influenza  A/California/2009 (H1N1)

CPU, CRO, Infectious Disease/Vaccine, Influenza, News

Influenza Challenge Research – WCCT Global Announces Ownership of Influenza A/California/2009 (H1N1)

Influenza Challenge Research is Now Available in the United States. Influenza Challenge Research now available for companies looking for a US based clinical research organization to conduct challenge clinical trials. WCCT Global is proud to announce the ownership of a recently circulating Influenza A/California/2009 (H1N1) virus for the purpose...read more

6 years ago.

Volunteers needed for paid studies now!

See Current Studies
Contact Us

Start typing and press Enter to search